Activated iNKT cells promote Vγ9Vδ2-T cell anti-tumor effector functions through the production of TNF-α-Reference-Cited by-同舟云学术

Activated iNKT cells promote Vγ9Vδ2-T cell anti-tumor effector functions through the production of TNF-α

Published:2012-02 Issue:2 Volume:142 Page:194-200
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Schneiders Famke L.,de Bruin Renée C.G.,Santegoets Saskia J.A.M.,Bonneville Marc,Scotet Emmanuel,Scheper Rik J.,Verheul Henk M.W.,de Gruijl Tanja D.,van der Vliet Hans J.

Funder

The Netherlands Organization for Health Research and Development

Dutch Cancer Society

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference29 articles.

1. Human Vgamma9Vdelta2 T cells: promising new leads for immunotherapy of infections and tumors;Bonneville;Curr. Opin. Immunol.,2006

2. Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells;Gober;J. Exp. Med.,2003

3. Sensing cell stress and transformation through Vgamma9Vdelta2 T cell-mediated recognition of the isoprenoid pathway metabolites;Bonneville;Microbes. Infect.,2005

4. V gamma 9V delta 2 T cell response to colon carcinoma cells;Corvaisier;J. Immunol.,2005

5. A novel population of T-cell receptor alpha beta-bearing thymocytes which predominantly expresses a single V beta gene family;Fowlkes;Nature,1987

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A bispecific T cell engager recruits both type 1 NKT and Vγ9Vδ2-T cells for the treatment of CD1d-expressing hematological malignancies;Cell Reports Medicine;2023-03

2. The Role of CD1d and MR1 Restricted T Cells in the Liver;Frontiers in Immunology;2018-10-30

3. Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression;Frontiers in Immunology;2018-09-21

4. Reciprocal Crosstalk between Dendritic Cells and Natural Killer T Cells: Mechanisms and Therapeutic Potential;Frontiers in Immunology;2017-05-24

5. Prevention of Vγ9Vδ2 T Cell Activation by a Vγ9Vδ2 TCR Nanobody;The Journal of Immunology;2016-11-28